Page 74 - 南京医科大学自然版
P. 74
第45卷第10期
·1442 · 南 京 医 科 大 学 学 报 2025年10月
Conflict of Interests: cance and immune characteristics of APOE in gastric
All authors declare no conflict of interests. cancer[J]. Aging(Albany NY),2023,15(23):13840-
作者贡献声明: 13853
王勇、丁磊、董汇昱负责实验实施、收集数据、统计分析、 [11]HUANG J P,SUN W,WANG Z H,et al. FTO suppresses
论文撰写与修改。梁超、李杰负责课题设计、数据审核、论文 glycolysis and growth of papillary thyroid cancer via
修改与审阅。 decreasing stability of APOE mRNA in an N6 ⁃ methyl⁃
Author’s Contributions: adenosine⁃dependent manner[J]. J Exp Clin Cancer Res,
WANG Yong,DING Lei,and DONG Huiyu were responsi⁃ 2022,41(1):42
ble for experimental implementation,data collection,statistical [12] ASHRAFIZADEH M,PASKEH M D A,MIRZAEI S,et
analysis,paper writing and revision. LIANG Chao and LI Jie al. Targeting autophagy in prostate cancer:preclinical
were responsible for the subject design,data review,manuscript and clinical evidence for therapeutic response[J]. J Exp
revision and review. Clin Cancer Res,2022,41(1):105
[13]GILLESSEN S,BOSSI A,DAVIS I D,et al. Management
[参考文献]
of patients with advanced prostate cancer. partⅠ:inter⁃
[1] SEKHOACHA M,RIET K,MOTLOUNG P,et al. Prostate
mediate ⁃/high ⁃ risk and locally advanced disease,bio⁃
cancer review:genetics,diagnosis,treatment options,and chemical relapse,and side effects of hormonal treatment:
alternative approaches[J]. Molecules,2022,27(17):
report of the advanced prostate cancer consensus confe⁃
5730 rence 2022[J]. Eur Urol,2023,83(3):267-293
[2] CHEN H T,PANG B R,ZHOU C,et al. Prostate cancer⁃
[14]DELUCE J E,CARDENAS L,LALANI A K,et al. Emerg⁃
derived small extracellular vesicle proteins:the hope in ing biomarker ⁃ guided therapies in prostate cancer[J].
diagnosis,prognosis,and therapeutics[J]. J Nanobiotech⁃
Curr Oncol,2022,29(7):5054-5076
nology,2023,21(1):480 [15]KEMP S B,CARPENTER E S,STEELE N G,et al. Apoli⁃
[3] LIU J Z,DONG L,ZHU Y J,et al. Prostate cancer treat⁃ poprotein E promotes immune suppression in pancreatic
ment⁃China’s perspective[J]. Cancer Lett,2022,550: cancer through NF ⁃ κB ⁃ mediated production of CXCL1
215927 [J]. Cancer Res,2021,81(16):4305-4318
[4] PARKER C,CASTRO E,FIZAZI K,et al. Prostate cancer: [16]WU C Y,LI T,CHENG W J. The correlation between
ESMO Clinical Practice Guidelines for diagnosis,treat⁃ APOE expression and the clinical characteristics and
ment and follow⁃up[J]. Ann Oncol,2020,31(9):1119- prognosis of patients with endometrial cancer[J]. Medi⁃
1134 cine(Baltimore),2022,101(37):e30536
[5] KUMAR AM S,RAJAN P,ALKHAMEES M,et al. Pros⁃ [17]FERRI⁃BORGOGNO S,ZHU Y,SHENG J T,et al. Spa⁃
tate cancer theragnostics biomarkers:an update[J]. tial transcriptomics depict ligand ⁃ receptor cross ⁃ talk
Investig Clin Urol,2024,65(6):527-539 heterogeneity at the tumor⁃stroma interface in long⁃term
[6] LEE S,DEVANNEY N A,GOLDEN L R,et al. APOE ovarian cancer survivors[J]. Cancer Res,2023,83(9):
modulates microglial immunometabolism in response to 1503-1516
age,amyloid pathology,and inflammatory challenge[J]. [18]LIU H K,GAO J W,FENG M,et al. Integrative molecular
Cell Rep,2023,42(3):112196 and spatial analysis reveals evolutionary dynamics and
[7] RAULIN A C,DOSS S V,TROTTIER Z A,et al. ApoE in tumor ⁃ immune interplay of in situ and invasive acral
Alzheimer’s disease:pathophysiology and therapeutic melanoma[J]. Cancer Cell,2024,42(6):1067-1085.e11
strategies[J]. Mol Neurodegener,2022,17(1):72 [19]ZHU L,BAO Y L,LIU Z J,et al. Gualou⁃Xiebai herb pair
[8] LIU Z,GAO Y,HAO F X,et al. Secretomes are a poten⁃ ameliorate atherosclerosis in HFD⁃induced ApoE -/- mice
tial source of molecular targets for cancer therapies and and inhibit the ox ⁃ LDL ⁃ induced injury of HUVECs by
indicate that APOE is a candidate biomarker for lung regulating the Nrf2⁃mediated ferroptosis[J]. J Ethnophar⁃
adenocarcinoma metastasis[J]. Mol Biol Rep,2014,41 macol,2024,326:117892
(11):7507-7523 [20]SAVIGNAC C,VILLENEUVE S,BADHWAR A,et al.
[9] HE L Y,SHI M C,REN S W,et al. Jun⁃APOE⁃LRP1 axis APOE alleles are associated with sex ⁃ specific structural
promotes tumor metastasis in colorectal cancer[J]. Biomol differences in brain regions affected in Alzheimer’s disease
Biomed,2023,23(6):1026-1037 and related dementia[J]. PLoS Biol,2022,20(12):
[10] PENG X L,CAI Z,CHEN D S,et al. Prognostic signifi⁃ (下转第1512页)

